The project added a new aseptic processing line, as well as an additional 28,000 sq. ft. of utility mezzanine space, to ...

Key opportunities in the blow-fill-seal (BFS) technology market include rising demand for sterile pharmaceutical packaging, growing biologics and vaccine production, increased preference for ...

The Slovenian unit of Swiss drugmaker Novartis said it has opened a new factory for sterile filing of biologics and xRNA medicines into syringes and vials, and sterile packaging in the Slovenian ...

The update to EU GMP Annex 1 offers market opportunities in aseptic operations, focusing on compliance with new standards. Key areas include contamination control, cleanroom design, and advanced ...

First antibody-drug conjugate facility to receive three provincial regulatory approvals for segmented manufacturing.

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...

Nutrition from Water (NXW), the New Zealand microalgae ingredients company behind the Marine Whey protein range, has agreed ...

CSL Seqirus’ Tullamarine facility is redefining Australia’s role in global vaccine manufacturing through advanced cell-based ...

For large-scale distributors and international hotel chains, sourcing reliable Premium Natural Bamboo Skewer Solutions involves a rigorous evaluation of regulatory compliance and manufacturing ...

MD Jayatheertha Chary says that upcoming facilities in Nagpur, Bihar, Punjab, Gujarat and Andhra Pradesh will expand presence ...

This scheme has consistently delivered the best returns in its Equity - Other category across . This scheme has maintained a relatively low level of volatility within its Equity - Other category over ...